Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 14 Aug 2025

Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the Middle East and Africa: a cross-sectional study

in Drugs Outcomes Research and Policies

Sam Salek
Hani Sabbour
Naji Alamuddin
Fatheya Alawadi
Hessa Alkandari
Wael Almahmeed
Samir H Assaad-Khalil
Emel Mashaki Ceyhan
Jihad Haddad
Landman Lombard

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558515

Original Research

Published on 14 Aug 2025

Beyond efficacy parity: a novel cost-equilibrium framework for value assessment of competing third-line therapies in metastatic colorectal cancer

in Drugs Outcomes Research and Policies

Shunlong Ou
Bingjie Wang
Jing Luo
Qian Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606742

345 views

Review

Published on 13 Aug 2025

Advancing drug-drug interactions research: integrating AI-powered prediction, vulnerable populations, and regulatory insights

in Drugs Outcomes Research and Policies

Wenzhun Huang
Xiao Wang
Yunhao Chen
Changqing Yu
Shanwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1618701

294 views

Original Research

Published on 13 Aug 2025

Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars

in Drugs Outcomes Research and Policies

Maximilian Otte
Zoltán Kaló
Hussain Abdulrahman Al-Omar
Meindert Boysen
Yingyao Chen
Ana Paula Beck Da Silva Etges
Guvenc Kockaya
Iñaki Gutierrez-Ibarluzea
Ahmed Mohammed Seyam
Deirdre Mullen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599013

570 views

Original Research

Accepted on 12 Aug 2025

Research on strategies for enhancing drug knowledge dissemination on Chinese social media WeChat public accounts based on text mining technology

in Drugs Outcomes Research and Policies

Xihui Yu
Xiaotong Chen
Xia Yan
Xuejun Wu
Yizhi Zhang
Xiajiong Luo
Weihao Ma
Hongbo Fu
Yaofeng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569863

183 views

Original Research

Accepted on 11 Aug 2025

Determinants of Orphan Drug Health Technology Assessment in South Korea: An Empirical Analysis

in Drugs Outcomes Research and Policies

Se Hee Lee
Sungkyung Lee
Jong Hyuk Lee
Joon Seok Bang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619984

135 views

Systematic Review

Accepted on 11 Aug 2025

Efficacy and safety of oral anticoagulants in the treatment of Chronic Kidney Disease with Atrial Fibrillation or Venous Thromboembolism: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Qinan Yin
Xingyue Zheng
Xiaoqing Ni
Yin Wang
Xuefei Huang
Yujie Song
Lizhu Han
Youjin Huang
Bian Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1615284

122 views

Original Research

Published on 11 Aug 2025

Key elements and theoretical logic of application of PIC/S standards in improving drug GMP inspections in China: an analysis based on grounded theory

in Drugs Outcomes Research and Policies

Di Hu
Ping Liao
Yuwen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559004

310 views

Systematic Review

Published on 11 Aug 2025

What is the best first-line combination regimen for advanced EGFR-mutated non-small cell lung cancer: a network meta-analysis and systemic review

in Drugs Outcomes Research and Policies

Chuang Yang
Yunfei Wang
Yiyong Sun
Ying Sun
Rongyu Zhang
Chengjun Wang
Yanan Song
Wen Zhao
Jisheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572115

505 views

Original Research

Accepted on 08 Aug 2025

Quantitative Evaluation of Dual-Channel Drug Supply Policy on Nationally Negotiated Anti-Tumor Drugs In Xuzhou: Based on Interrupted Time Series Analysis

in Drugs Outcomes Research and Policies

Zhaohui Qin
Shuo Xu
Qi Li
Xueling Guan
檬何
Min Zhou
Yan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571822

154 views

Original Research

Accepted on 08 Aug 2025

Tracking a Decade of Phase I Clinical Trials in Italy: Trends and Insights from National and European Registries Amid Regulatory Change

in Drugs Outcomes Research and Policies

ELEONORA DE PAOLA
LUNA DEL BONO
DIEGO ALEJANDRO DRI
RAFFAELLA MAIONE
SANDRA PETRAGLIA
FABRIZIO GALLICCIA
GIOVANNI GORI

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661186

229 views

Original Research

Accepted on 07 Aug 2025

Efficacy and Safety of Different Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in the General Population and Solid Organ Transplant Recipients: A Network Meta-Analysis

in Drugs Outcomes Research and Policies

Bohan Luo
Zhuang Sun
Han Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584612

126 views

Original Research

Accepted on 04 Aug 2025

Mirabegron for intramural ureteral stones with vesical irritability: a prospective study

in Drugs Outcomes Research and Policies

Mengjun Dai
Yuhang She
Hao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1639032

105 views

Original Research

Published on 04 Aug 2025

Assessing the effects of online educational intervention on pharmaceutical promotions: a pre–post study among medical and pharmacy students in Pakistan

in Drugs Outcomes Research and Policies

Ali Hassan Gillani
Hafsa Arshad
Caijun Yang
Muhammad Arshed
Naveel Atif
Kamran Bashir
Hafiz Muhammad Abbas Malik
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1616631

571 views

Brief Research Report

Accepted on 01 Aug 2025

Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL

in Drugs Outcomes Research and Policies

Ling Deng
Chenchen Liu
Yiyu Guo
Chunyan Liu
Rong Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542837

348 views

Original Research

Accepted on 31 Jul 2025

Drug lag and associated factors of orphan drugs approved by the U.S. in China

in Drugs Outcomes Research and Policies

Qihui Mo
Jiaqi He
Qixiang Guo
Yue YANG

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595497

172 views